T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did...

31
1 2/26/2019 T HE FDA T OOLS TO T ACKLE THE JUUL E PIDEMIC

Transcript of T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did...

Page 1: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

12/26/2019

THE FDA TOOLS TO TACKLE THEJUUL EPIDEMIC

Page 2: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

THE PUBLIC HEALTH LAW CENTER

1/23/2019 2

Page 3: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

LEGAL TECHNICAL ASSISTANCE

1/23/2019 3

Legal Research

Policy Development, Implementation, Defense

Publications

Trainings

Direct Representation

Lobby

Page 4: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

1/23/2019 4

Photo credit: Sam Bradd https://drawingchange.com/gathering-wisdom-visuals-for-a-healthy-future/

Page 5: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

OVERVIEW

1. E-Cigarette Epidemic– No End in Sight– How Did We Get Here?– 2017 Regulatory Plan

2. Premarket Review and Enforcement Discretion

3. JUUL4. FDA Action5. State and Local Regulation

52/26/2019

Page 6: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

E-CIGARETTE EPIDEMIC

62/26/2019

Page 7: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

$-

$50.00

$100.00

$150.00

$200.00

$250.00

$300.00

$350.00

Nov-13 May-14 Nov-14 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 May-18 Nov-18

Monthly E-Cigarette Sales (in Millions)

Market Total JUUL

E-CIGARETTE EPIDEMICNO END IN SIGHT

2/26/2019 7

Nielsen All-Channel Data

Page 8: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

$-

$50.00

$100.00

$150.00

$200.00

$250.00

$300.00

$350.00

Nov-13 May-14 Nov-14 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 May-18 Nov-18

Monthly E-Cigarette Sales (in Millions)

Market Total JUUL

E-CIGARETTE EPIDEMICNO END IN SIGHT

2/26/2019 8

Nielsen All-Channel Data

13.4%

16.0%

11.3% 11.7%

NYTS Survey Periods

20.8%

Page 9: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

$-

$50.00

$100.00

$150.00

$200.00

$250.00

$300.00

$350.00

Nov-13 May-14 Nov-14 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 May-18 Nov-18

Monthly E-Cigarette Sales (in Millions)

Market Total JUUL

E-CIGARETTE EPIDEMICNO END IN SIGHT

2/26/2019 9

Nielsen All-Channel Data

13.4%

16.0%

11.3% 11.7%

NYTS Survey Periods

20.8%

Page 10: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

E-CIGARETTE EPIDEMICCDC’S CURRENT TOBACCO USE AMONG HIGH SCHOOL STUDENTS

2/26/2019 10

Page 11: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

E-CIGARETTE EPIDEMICCDC’S CURRENT TOBACCO USE AMONG HIGH SCHOOL STUDENTS

2/26/2019 11

2018: 20.8%

Page 12: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

E-CIGARETTE EPIDEMICCDC’S CURRENT TOBACCO USE AMONG HIGH SCHOOL STUDENTS

2/26/2019 12

Page 13: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

E-CIGARETTE EPIDEMICCDC’S CURRENT TOBACCO USE AMONG HIGH SCHOOL STUDENTS

2/26/2019 13

Page 14: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

AUTHORITY AND THE DEEMING RULEHOW DID WE GET HERE?

142/26/2019

Page 15: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

15

Nielsen All-Channel Data

$-

$50.00

$100.00

$150.00

$200.00

$250.00

$300.00

$350.00

Nov-13 May-14 Nov-14 May-15 Nov-15 May-16 Nov-16 May-17 Nov-17 May-18 Nov-18

Monthly E-Cigarette Sales (in millions)

Market Total JUUL

AUTHORITY AND THE DEEMING RULEHOW DID WE GET HERE?

2/26/2019

Deem

ing Rule

Effective Date

Page 16: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

DEEMING RULEWHAT IS ENFORCEMENT DISCRETION?

2/26/2019 16

Page 17: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

DEEMING RULEHOW DID WE GET HERE?

17

8/8/20198/8/2016 8/8/2018 8/8/2022

Continued marketing without application Continued marketing with application

Marketing with affirmative order

2/26/2019

2016 Final Deeming Rule (Deadlines for E-cigarettes)

“Freeze Date” Today

Page 18: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

FDA TOBACCO & NICOTINE REGULATORY PLAN

182/26/2019

Page 19: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

FDA TOBACCO & NICOTINE REGULATORY PLAN

19

2017 Regulatory Plan (Deadlines for E-cigarettes)

8/8/2016 8/8/20228/8/20198/8/2018

8/8/20198/8/2016 8/8/2018 8/8/2022

Continued marketing without application Continued marketing with application

Marketing with affirmative order

2/26/2019

“Freeze Date” Today

2016 Final Deeming Rule (Deadlines for E-cigarettes)

Page 20: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

JUUL

202/26/2019

Page 21: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

JUUL

2/26/2019 21

8/8/2016 8/8/20228/8/20198/8/2018

Continued marketing without application Continued marketing with application

Marketing with affirmative order

“Freeze Date”

2017 Regulatory Plan (Deadlines for E-cigarettes)

Page 22: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

JUUL

2/26/2019 22

8/8/2016 8/8/20228/8/20198/8/2018

“Freeze Date”

6/1/2015JUUL enters the market

Continued marketing without application Continued marketing with application

Marketing with affirmative order

2017 Regulatory Plan (Deadlines for E-cigarettes)

Page 23: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

JUUL

2/26/2019 23

8/8/2016 8/8/20228/8/20198/8/20186/1/2015JUUL enters the market 11/2018

Reynolds releases Vuse Alto

2/2018 ITGreleases myBlu

Continued marketing without application Continued marketing with application

Marketing with affirmative order

2017 Regulatory Plan (Deadlines for E-cigarettes)

“Freeze Date”

Page 24: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

FDA Action Date

Public Hearing on Cessation Strategies for Youth January 26, 2018

Nicotine Reduction Information Gathering March 16, 2018

Flavored Products Information Gathering March 21, 2018

JUUL Collection of Information April 8, 2018

E-liquid Warning Letters about Specific Flavors May 1, 2018

JUUL “Blitz” September 12, 2018

FDA raids JUUL HQ October 2, 2018

242/26/2019

FDA RESPONSE

Page 25: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

FDA Action Date

Public Hearing on Cessation Strategies for Youth January 26, 2018

Nicotine Reduction Information Gathering March 16, 2018

Flavored Products Information Gathering March 21, 2018

JUUL Collection of Information April 8, 2018

E-liquid Warning Letters about Specific Flavors May 1, 2018

JUUL “Blitz” September 12, 2018

FDA raids JUUL HQ October 2, 2018

Announcement of FDA’s Intentions November 15, 2015

252/26/2019

FDA RESPONSE

Page 26: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

ENFORCEMENT DISCRETION

2/26/2019 26

Oh, you actually thought letting me stayup way past my usual bedtime wouldmake me sleep later in the morning?Welcome to 5:48 am . . .

Page 27: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

ENFORCEMENT DISCRETION

2/26/2019 27

• Flavored products• Adult-only facilities• Internet sales• Nicotine salts• Limit nicotine content

to the user

Page 28: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

STATE AND LOCAL REGULATION

282/26/2019

Page 29: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

CONTACT THE FDA TEAM

651.290.7612

[email protected]

www.publichealthlawcenter.org

@DesmondJenson

facebook.com/publichealthlawcenter

292/26/2019

651.290.7666

[email protected]

www.publichealthlawcenter.org

@publichealthlawcenter

facebook.com/publichealthlawcenter

Page 30: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

302/26/2019

Page 31: T FDA TOOLS TO TACKLE THE JUUL EPIDEMIC · 1. E-Cigarette Epidemic – No End in Sight – How Did We Get Here? – 2017 Regulatory Plan 2. Premarket Review and Enforcement Discretion

CONTACT THE FDA TEAM

651.290.7612

[email protected]

www.publichealthlawcenter.org

@DesmondJenson

facebook.com/publichealthlawcenter

312/26/2019

651.290.7666

[email protected]

www.publichealthlawcenter.org

@publichealthlawcenter

facebook.com/publichealthlawcenter


E-CIGARETTES & JUUL

E-CIGARETTES & JUUL

Marketing Authorization procedures & premarket requirements sea countries

Marketing Authorization procedures & premarket requirements sea countries

Submission of Premarket Notifications for Magnetic Resonance ...

Submission of Premarket Notifications for Magnetic Resonance ...

Model Great Lift · Design by Jens Juul Eilersen

Model Great Lift · Design by Jens Juul Eilersen

Guidance for the Content of Premarket Submissions for ... · • Premarket Notification (510(k)) including Traditional, Special, and Abbreviated submissions • Premarket Approval

Guidance for the Content of Premarket Submissions for ... · • Premarket Notification (510(k)) including Traditional, Special, and Abbreviated submissions • Premarket Approval

JUUL Retailer Control Access Standards Guide

JUUL Retailer Control Access Standards Guide

Quality System Information for Certain Premarket Application … · Quality System Information for Certain Premarket Application Reviews; Guidance for Industry and FDA Staff Document

Quality System Information for Certain Premarket Application … · Quality System Information for Certain Premarket Application Reviews; Guidance for Industry and FDA Staff Document

Intelligent Ambience - Jørgen Juul - 2009 09 07

Intelligent Ambience - Jørgen Juul - 2009 09 07

JUUL Nicotine Addiction Lawsuits...JUUL is busy trying to clean up its act now, but the damage has been done. If you’re one of the tens of thousands of people who used JUUL products

JUUL Nicotine Addiction Lawsuits...JUUL is busy trying to clean up its act now, but the damage has been done. If you’re one of the tens of thousands of people who used JUUL products

Content of Premarket Submissions for Management of ...fdagov-meddev-gen/... · Contains Nonbinding Recommendations Draft – Not for Implementation Content of Premarket Submissions

Content of Premarket Submissions for Management of ...fdagov-meddev-gen/... · Contains Nonbinding Recommendations Draft – Not for Implementation Content of Premarket Submissions

The Youth Vaping Epidemic: How flavors addict kids Doc… · maker, Juul, stopped selling all flavors of their pods except for menthol and tobacco. • Mint/menthol flavors are the

The Youth Vaping Epidemic: How flavors addict kids Doc… · maker, Juul, stopped selling all flavors of their pods except for menthol and tobacco. • Mint/menthol flavors are the

MIA JUUL - imgmodels.com

MIA JUUL - imgmodels.com

Submission of Premarket Notifications for Magnetic ...fdagov-meddev-gen/... · Contain Nonbinding Recommendations . Submission of Premarket Notifications for Magnetic Resonance Diagnostic

Submission of Premarket Notifications for Magnetic ...fdagov-meddev-gen/... · Contain Nonbinding Recommendations . Submission of Premarket Notifications for Magnetic Resonance Diagnostic

THE TEEN VAPING EPIDEMIC - Napoli Shkolnik › wp-content › uploads › Verdict-12... · 2019-10-25 · THE TEEN VAPING EPIDEMIC Almost overnight, Juul became the leading provider

THE TEEN VAPING EPIDEMIC - Napoli Shkolnik › wp-content › uploads › Verdict-12... · 2019-10-25 · THE TEEN VAPING EPIDEMIC Almost overnight, Juul became the leading provider

Premarket Notification-510k - I 3 ConsultingFDA PREMARKET NOTIFICATION SUBMISSION 510 (k) by Mary Roopsy Premarket Notification-510k The class I, II and III medical devices which are

Premarket Notification-510k - I 3 ConsultingFDA PREMARKET NOTIFICATION SUBMISSION 510 (k) by Mary Roopsy Premarket Notification-510k The class I, II and III medical devices which are

Premarket Notification [510(k)] Submissions for Chemical

Premarket Notification [510(k)] Submissions for Chemical

Premarket Testing and Validation 2.0

Premarket Testing and Validation 2.0

Guidance Document for Premarket Notification Submissions ... Guidance Document for Premarket Notification Submissions for Nitric Oxide ... Guidance Document for Premarket Notification

Guidance Document for Premarket Notification Submissions ... Guidance Document for Premarket Notification Submissions for Nitric Oxide ... Guidance Document for Premarket Notification

JUUL & THE GUINEA PIG GENERATION - Public Health Law › sites › default › ... · 2018-07-18 · JUUL & the Guinea Pig Generation p_2 Q: What is JUUL? A: Launched in 2015, JUUL

JUUL & THE GUINEA PIG GENERATION - Public Health Law › sites › default › ... · 2018-07-18 · JUUL & the Guinea Pig Generation p_2 Q: What is JUUL? A: Launched in 2015, JUUL

Premarket Studies of Implantable Minimally Invasive ...fdagov-meddev-gen/... · Contains Nonbinding Recommendations Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical

Premarket Studies of Implantable Minimally Invasive ...fdagov-meddev-gen/... · Contains Nonbinding Recommendations Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical